Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

GalNAc-T9 Activators

GalNAc-T9 represents an intriguing enzyme in the family of GalNAc-transferases, key players in the intricate process of O-linked glycosylation. This specific enzyme facilitates the transfer of N-acetylgalactosamine onto serine and threonine residues within proteins, a fundamental step in the synthesis of the glycoprotein mucin. The expression of GalNAc-T9 within cellular systems is a finely tuned process, influenced by a variety of intracellular and extracellular signals. Understanding the regulation of GalNAc-T9 is pivotal for comprehending the glycosylation patterns that are critical for numerous cellular functions, including cell signaling, protein stability, and the establishment of cell-cell interactions. Research into the molecular pathways that govern the expression of GalNAc-T9 enzyme can shed light on the complex regulatory networks that dictate the glycosylation landscape within cells, offering insights into the basic principles of cellular operation and the maintenance of cellular health.

Various biochemical compounds have been identified that can potentially induce the expression of GalNAc-T9. Compounds such as retinoic acid and beta-estradiol can have a significant role in the transcriptional activation of genes, including those involved in glycosylation processes. These molecules bind to specific receptors that interact with DNA at promoter regions of target genes to stimulate transcription. Other molecules, like butyrate and its derivative sodium butyrate, act epigenetically through the inhibition of histone deacetylases, which leads to a more relaxed chromatin state and can result in increased transcriptional activity. Additionally, agents such as 5-Azacytidine and epigallocatechin gallate may induce expression by altering the epigenetic marks on the DNA, thereby affecting gene expression profiles. The induction of stress responses within the cell, for instance through the administration of tunicamycin or thapsigargin, can also lead to the upregulation of proteins involved in glycosylation, as the cell endeavors to manage the stress by modifying its protein folding machinery. Collectively, these activators highlight the diverse molecular mechanisms through which the expression of GalNAc-T9 can be regulated, further emphasizing the complexity of cellular regulation and the intricacies of protein glycosylation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid can upregulate gene expression by binding to retinoic acid receptors, potentially stimulating the transcription of GalNAc-T9 by altering transcriptional control at gene promoter sites.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin gallate has been shown to possess epigenetic modulatory properties that may stimulate the transcription machinery related to the expression of GalNAc-T9 through alterations in DNA methylation and histone modification patterns.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferases, 5-Azacytidine may reactivate epigenetically silenced genes, thereby potentially increasing the expression levels of GalNAc-T9 through demethylation of the gene's promoter region.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin may elevate intracellular cAMP, which in turn could activate protein kinase A (PKA) and subsequent transcription factors that stimulate GalNAc-T9 gene transcription.

1α,25-Dihydroxyvitamin D3

32222-06-3sc-202877B
sc-202877A
sc-202877C
sc-202877D
sc-202877
50 µg
1 mg
5 mg
10 mg
100 µg
$220.00
$645.00
$1000.00
$1500.00
$440.00
32
(2)

The hormonally active form of vitamin D3, Calcitriol, can bind to its receptor and stimulate the transcription of genes involved in calcium metabolism, potentially including the upregulation of GalNAc-T9.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A, as an HDAC inhibitor, may promote histone acetylation, thereby stimulating an increase in the transcriptional activity of genes such as GalNAc-T9 by allowing transcription factor access.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin may induce the unfolded protein response (UPR) by inhibiting N-linked glycosylation, which can lead to the upregulation of several genes involved in protein folding, including possibly GalNAc-T9.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin could induce the expression of GalNAc-T9 by disrupting calcium homeostasis within the endoplasmic reticulum, triggering the UPR and leading to an adaptive response that may include the upregulation of GalNAc-T9.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Similar to butyrate, sodium butyrate might stimulate the expression of GalNAc-T9 through inhibition of HDACs, resulting in an open chromatin conformation and subsequent transcriptional activation of the gene.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A can bind to DNA and selectively inhibit Sp1 transcription factor binding to GC-rich promoter regions, potentially stimulating the transcription of specific genes, including those encoding glycosyltransferases like GalNAc-T9.